Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex net income
Net income is the profit left for shareholders after every expense, interest and tax.
Vaccinex's net income for the twelve months ending Dec 31, 2024 was -$18.63M. For fiscal 2024 it was -$18.63M. The highest annual figure on record is -$18.63M in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$18.63M | – |
| FY2023 | Dec 31, 2023 | -$20.25M | – |
| FY2022 | Dec 31, 2022 | -$19.82M | – |
| FY2021 | Dec 31, 2021 | -$22.38M | – |
| FY2020 | Dec 31, 2020 | -$28.85M | – |
| FY2019 | Dec 31, 2019 | -$31.86M | – |
| FY2018 | Dec 31, 2018 | -$29.52M | – |
| FY2017 | Dec 31, 2017 | -$18.72M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$3.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.73M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.90M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.32M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.91M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.06M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.96M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.08M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.76M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.38M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.60M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.63M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.21M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.97M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.57M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.45M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.75M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.50M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.15M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.33M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.64M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.83M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.07M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.45M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.60M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.61M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.59M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.54M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.88M | – |
See a number that looks wrong?